FDA Urges Firms To Control Metal Impurities From Equipment And Containers
Executive Summary
Drug makers working to comply with new ICH Q3D metal impurity standards should pay special attention to the possibility of metals leaching from manufacturing equipment and container closures, an FDA official says at agency workshop.
You may also be interested in...
ICH Q3D Metal Impurities Guidance Issued By FDA, EMA, Health Canada
Regulatory members of the International Council on Harmonization have issued Q3D guidance on metal impurities that, while harmonized, differs in emphasis.
Program Participants Urge The FDA To Adopt Some Pharmaceutical Quality Metrics And Avoid Others
Site-based metrics praised; lot acceptance rates, invalidated OOS rates discouraged. Agency official admits some proposed metrics were “not the best.”
EU GMP Annex I Is A Top Priority For EMA While Industry Has Lingering Concerns
Questions about contamination control strategy raised as European Medicines Agency makes EU GMP Annex I revision a top priority in its 2021 work plan.